NASDAQ: PTPIPetros Pharmaceuticals Inc Stock Ownership - Who owns Petros Pharmaceuticals?
Insider buying vs selling
Have Petros Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when PTPI insiders and whales buy or sell their stock.
PTPI Shareholders
What type of owners hold Petros Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John D. Shulman | 10.66% | 5,703,544 | $74.15k | Insider |
| Joshua Silverman | 1.89% | 1,011,237 | $13.15k | Insider |
| Fady Boctor | 0.93% | 499,645 | $6.50k | Insider |
| Bruce Bernstein | 0.58% | 308,346 | $4.01k | Insider |
| Wayne Remell Walker | 0.30% | 158,314 | $2.06k | Insider |
| Mitchell Arnold | 0.28% | 150,390 | $1.96k | Insider |
| Geode Capital Management LLC | 0.07% | 36,184 | $470.39 | Institution |
| Vanguard Group Inc | 0.06% | 31,811 | $413.54 | Institution |
| Blackrock Inc | 0.03% | 16,128 | $209.66 | Institution |
| Ubs Group Ag | 0.02% | 12,992 | $168.90 | Institution |
PTPI vs Pharmaceutical Stocks
Petros Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.